SCHEMBL16784200

SCHEMBL16784200

COc1ccc(/C=C/CCc2ccccc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.59
GPR52 Q9Y2T5 2/20 0.58
RAB9A P51151 2/20 0.52
ALDH1A1 P00352 4/20 0.52
LMNA P02545 2/20 0.52
MEN1 O00255 1/20 0.52
KMT2A Q03164 1/20 0.52
PLAAT3 P53816 1/20 0.52
PLAAT5 Q96KN8 1/20 0.52
PLAAT2 Q9NWW9 1/20 0.52
PLAAT4 Q9UL19 1/20 0.52
KDM4E B2RXH2 2/20 0.52
TP53 P04637 1/20 0.52
CYP3A4 P08684 1/20 0.52
TSHR P16473 1/20 0.52
GAA P10253 1/20 0.50
RECQL P46063 1/20 0.50
LTA4H P09960 1/20 0.50
MAPT P10636 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31197199 1.00 TRPA1 (0.59) TRPA1GPR52RAB9AALDH1A1LMNA
SCHEMBL9928581 0.91 CYP3A4 (0.57) TRPA1GPR52RAB9AALDH1A1LMNA
SCHEMBL31197198 0.85 TLR4 (0.46) GPR52RAB9AALDH1A1LMNAMEN1
SCHEMBL30543062 0.83 CYP3A4 (0.52) TRPA1GPR52RAB9AALDH1A1LMNA
SCHEMBL29850441 0.83 CYP3A4 (0.52) TRPA1GPR52RAB9AALDH1A1LMNA
SCHEMBL5632468 0.83 GPR52 (0.54) TRPA1GPR52RAB9AALDH1A1LMNA
SCHEMBL9954124 0.83 TRPA1 (0.63) TRPA1RAB9AALDH1A1LMNAMEN1
SCHEMBL3848013 0.83 TRPA1 (0.63) TRPA1RAB9AALDH1A1LMNAMEN1
SCHEMBL30742787 0.82 GPR52 (0.48) GPR52RECQLMAOB
SCHEMBL108688 0.82 GPR52 (0.48) GPR52RECQLMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9850261-B2 Silicon-based cross coupling agents and methods of their use THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2017-12-26 US disclosed
US-20170210766-A1 SILICON-BASED CROSS COUPLING AGENTS AND METHODS OF THEIR USE NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2017-07-27 US disclosed
US-9499660-B2 Silicon-based cross coupling agents and methods of their use THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2016-11-22 US disclosed
WO-2016011231-A1 SILICON-BASED CROSS COUPLING AGENTS AND METHODS OF THEIR USE THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2016-01-21 WO disclosed
US-20150152216-A1 SILICON-BASED CROSS COUPLING AGENTS AND METHODS OF THEIR USE THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 2015-06-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170210766-A1 SILICON-BASED CROSS COUPLING AGENTS AND METHODS OF THEIR USE RAD51, CA1, DCLRE1A TRPA1 4234/4885GPR52 4707/4885RAB9A 3757/4885
US-20150152216-A1 SILICON-BASED CROSS COUPLING AGENTS AND METHODS OF THEIR USE RAD51, CA1, DCLRE1A TRPA1 4234/4885GPR52 4707/4885RAB9A 3757/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.